Autoimmunity, Autoantibodies, and Autism Spectrum Disorder

Biological Psychiatry

Volumn 81, Issue 5, 2017, Pages 383-390

  Edmiston, Elizabeth ^a   Ashwood, Paul ^a,b   Van de Water, Judy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Autoimmunity; Immune; Maternal autoantibodies; Neurodevelopmental; Pregnancy

Indexed keywords

AUTOANTIBODY;

ANIMAL MODEL; ANTIBODY DETECTION; AUTISM; AUTOIMMUNITY; DISEASE ASSOCIATION; HUMAN; MENTAL DISEASE; NONHUMAN; PRIMATE MODEL; PRIORITY JOURNAL; REVIEW; ANIMAL; BRAIN; DISEASE MODEL; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; IMMUNOLOGY; PREGNANCY; RHESUS MONKEY; RISK FACTOR;

ANIMALS; AUTISM SPECTRUM DISORDER; AUTOANTIBODIES; AUTOIMMUNITY; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACACA MULATTA; MATERNAL-FETAL EXCHANGE; PREGNANCY; RISK FACTORS;

EID: 85006010485     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.08.031     Document Type: Review

References (97)

1. 1 American Psychiatric Association, editor (2013): Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association.
2. 2 Kanner, L., Irrelevant and metaphorical language in early infanitle autism. Am J Psychiatry 103 (1946), 242–246.
3. 3 Lord, C., Risi, S., Lambrecht, L., Cook, E.H., Leventhal, B.L., DiLavore, P.C., et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000), 205–223.
4. 4 Newschaffer, C.J., Croen, L.A., Daniels, J., Giarelli, E., Grether, J.K., Levy, S.E., et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 28 (2007), 235–258.
5. 5 Snow, A.V., Lecavalier, L., Houts, C., The structure of the Autism Diagnostic Interview-Revised: diagnostic and phenotypic implications. J Child Psychol Psychiatry Allied Disciplines 50 (2009), 734–742.
6. 6 Ousley, O., Cermak, T., Autism spectrum disorder: Defining dimensions and subgroups. Curr Dev Disord Rep 1 (2013), 20–28.
7. 7 McDougle, C.J., Landino, S.M., Vahabzadeh, A., O'Rourke, J., Zurcher, N.R., Finger, B.C., et al. Toward an immune-mediated subtype of autism spectrum disorder. Brain Res 1617 (2015), 72–92.
8. 8 Onore, C., Careaga, M., Ashwood, P., The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun 26 (2012), 383–392.
9. 9 Warren, R.P., Singh, V.K., Cole, P., Odell, J.D., Pingree, C.B., Warren, W.L., et al. Increased frequency of the null allele at the complement C4b locus in autism. Clin Exp Immunol 83 (1991), 438–440.
10. 10 Warren, R.P., Odell, J.D., Warren, W.L., Burger, R.A., Maciulis, A., Daniels, W.W., et al. Strong association of the third hypervariable region of HLA-DRβ1 with autism. J Neuroimmunol 67 (1996), 97–102.
11. 11 Torres, A.R., Sweeten, T.L., Cutler, A., Bedke, B.J., Fillmore, M., Stubbs, E.G., Odell, D., The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol 67 (2006), 346–351.
12. 12 Campbell, D.B., Li, C., Sutcliffe, J.S., Persico, A.M., Levitt, P., Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res 1 (2008), 159–168.
13. 13 Thanseem, I., Nakamura, K., Miyachi, T., Toyota, T., Yamada, S., Tsujii, M., et al. Further evidence for the role of MET in autism susceptibility. Neurosci Res 68 (2010), 137–141.
14. 14 Mostafa, G.A., Shehab, A.A., The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol 223 (2010), 115–119.
15. 15 Jung, J.Y., Kohane, I.S., Wall, D.P., Identification of autoimmune gene signatures in autism. Transl Psychiatry, 1, 2011 e63–e63.
16. 16 Torres, A.R., Westover, J.B., Gibbons, C., Johnson, R.C., Ward, D.C., Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism. Brain Behav Immun 26 (2012), 1122–1127.
17. 17 Comi, A.M., Zimmerman, A.W., Frye, V.H., Law, P.A., Peeden, J.N., Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14 (1999), 388–394.
18. 18 Atladóttir, H.O., Pedersen, M.G., Thorsen, P., Mortensen, P.B., Deleuran, B., Eaton, W.W., et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124 (2009), 687–694.
19. 19 Vinet, É., Pineau, C.A., Clarke, A.E., Scott, S., Fombonne, É., Joseph, L., et al. Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: results from a large population-based cohort. Arthritis Rheum 67 (2015), 3201–3208.
20. 20 Wu, S., Ding, Y., Wu, F., Li, R., Xie, G., Hou, J., et al. Family history of autoimmune diseases is associated with an increased risk of autism in children: A systematic review and meta-analysis. Neurosci Biobehav Rev 55 (2015), 322–332.
21. 21 Chen, S.-W., Zhong, X.-S., Jiang, L.-N., Zheng, X.-Y., Xiong, Y.-Q., Ma, S.-J., et al. Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis. Behav Brain Res 296 (2016), 61–69.
22. 22 Chess, S., Autism in children with congenital rubella. J Autism Child Schizophr 1 (1971), 33–47.
23. 23 Meyer, U., Nyffeler, M., Engler, A., Urwyler, A., Schedlowski, M., Knuesel, I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006), 4752–4762.
24. 24 Smith, S.E., Li, J., Garbett, K., Mirnics, K., Patterson, P.H., Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007), 10695–10702.
25. 25 Atladóttir, H.Ó., Thorsen, P., Østergaard, L., Schendel, D.E., Lemcke, S., Abdallah, M., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40 (2010), 1423–1430.
26. 26 Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol Med 17 (2011), 389–394.
27. 27 Garay, P.A., Hsiao, E.Y., Patterson, P.H., McAllister, A.K., Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development. Brain Behav Immun 31 (2013), 54–68.
28. 28 Ashwood, P., Van de Water, J., Is autism an autoimmune disease?. AutoimmunRev 3 (2004), 557–562.
29. 29 Braunschweig, D., Van de Water, J., Maternal autoantibodies in autism. Arch Neurol 69 (2012), 693–699.
30. 30 Fox, E., Amaral, D., Van de Water, J., Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol 72 (2012), 1327–1334.
31. 31 Fox-Edmiston, E., Van De Water, J., Maternal anti-fetal brain IgG autoantibodies and autism spectrum disorder: current knowledge and its implications for potential therapeutics. CNS Drugs 29 (2015), 715–724.
32. 32 Mallampalli, M.P., Davies, E., Wood, D., Robertson, H., Polato, F., Carter, C.L., Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report. J Women Health (2002) 22 (2013), 578–586.
33. 33 Hertz-Picciotto, I., Croen, L.A., Hansen, R., Jones, C.R., van de Water, J., Pessah, I.N., The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 114 (2006), 1119–1125.
34. 34 Christensen, D.L., Baio, J., Van Naarden Braun, K., Bilder, D., Charles, J., Constantino, J.N., et al. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ 65 (2016), 1–23.
35. 35 Money, J., Bobrow, N.A., Clarke, F.C., Autism and autoimmune disease: A family study. JAutism Child Schizophr 1 (1971), 146–160.
36. 36 Croen, L.A., Grether, J.K., Yoshida, C.K., Odouli, R., Van de Water, J., Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch Pediatr Adolesc Med 159 (2005), 151–157.
37. 37 Keil, A., Daniels, J.L., Forssen, U., Hultman, C., Cnattingius, S., Söderberg, K.C., et al. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology 21 (2010), 805–808.
38. 38 Christen, U., von Herrath, M.G., Initiation of autoimmunity. Curr Opin Immunol 16 (2004), 759–767.
39. 39 Ashwood, P., Van de Water, J., A review of autism and the immune response. Clin Dev Immunol 11 (2004), 165–174.
40. 40 Garay, P.A., McAllister, A.K., Novel roles for immune molecules in neural development: Implications for neurodevelopmental disorders. Front Synaptic Neurosci, 2, 2010 136-136.
41. 41 Filiano, A.J., Gadani, S.P., Kipnis, J., Interactions of innate and adaptive immunity in brain development and function. Brain Res 1617 (2015), 18–27.
42. 42 Gluecksohn-Waelsch, S., The effect of maternal immunization against organ tissues on embryonic differentiation in the mouse. Development 5 (1957), 83–92.
43. 43 Adinolfi, M., Beck, S.E., Haddad, S.A., Seller, M.J., Permeability of the blood-cerebrospinal fluid barrier to plasma proteins during foetal and perinatal life. Nature 259 (1976), 140–141.
44. 44 Plum, F., The concept of a blood-brain barrier. Ann Neurol, 9, 1981 622–622.
45. 45 Adinolfi, M., The development of the human blood-CSF brain barrier. Dev Med Child Neurol 27 (1985), 532–537.
46. 46 Karpiak, S.E. Jr, Rapport, M.M., Behavioral changes in 2-month-old rats following prenatal exposure to antibodies against synaptic membranes. Brain Res 92 (1975), 405–413.
47. 47 Rick, J.T., Gregson, A.N., Leibowitz, S., Adinolfi, M., Behavioural changes in adult rats following administration of antibodies again brain gangliosides. Dev Med Child Neurol 22 (1980), 719–724.
48. 48 Warren, R.P., Cole, P., Odell, J.D., Pingree, C.B., Warren, W.L., White, E., et al. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry 29 (1990), 873–877.
49. 49 Dalton, P., Deacon, R., Blamire, A., Pike, M., McKinlay, I., Stein, J., et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53 (2003), 533–537.
50. 50 Braunschweig, D., Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Croen, L.A., et al. Autism: Maternally derived antibodies specific for fetal brain proteins. Neurotoxicology 29 (2008), 226–231.
51. 51 Zimmerman, A.W., Connors, S.L., Matteson, K.J., Lee, L.C., Singer, H.S., Castaneda, J.A., Pearce, D.A., Maternal antibrain antibodies in autism. Brain Behav Immun 21 (2007), 351–357.
52. 52 Singer, H.S., Morris, C.M., Gause, C.D., Gillin, P.K., Crawford, S., Zimmerman, A.W., Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol 194 (2008), 165–172.
53. 53 Croen, L.A., Braunschweig, D., Maternal mid-pregnancy autoantibodies to fetal brain protein: The early markers for autism study. Biol Psychiatry 64 (2008), 583–588.
54. 54 Heuer, L., Braunschweig, D., Ashwood, P., Van de Water, J., Campbell, D.B., Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry, 1, 2011, e48.
55. 55 Brimberg, L., Sadiq, A., Gregersen, P.K., Diamond, B., Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry 18 (2013), 1171–1177.
56. 56 Braunschweig, D., Duncanson, P., Boyce, R., Hansen, R., Ashwood, P., Pessah, I.N., et al. Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord 42 (2012), 1435–1445.
57. 57 Nordahl, C.W., Braunschweig, D., Iosif, A.-M., Lee, A., Rogers, S., Ashwood, P., et al. Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun 30 (2013), 61–65.
58. 58 Akum, B.F., Chen, M., Gunderson, S.I., Riefler, G.M., Scerri-Hansen, M.M., Firestein, B.L., Cypin regulates dendrite patterning in hippocampal neurons by promoting microtubule assembly. Nat Neurosci 7 (2004), 145–152.
59. 59 Lopes, M.H., Hajj, G.N., Muras, A.G., Mancini, G.L., Castro, R.M., Ribeiro, K.C., et al. Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci 25 (2005), 11330–11339.
60. 60 Charrier, E., Reibel, S., Rogemond, V., Aguera, M., Thomasset, N., Honnorat, J., Collapsin response mediator proteins (CRMPs). Mol Neurobiol 28 (2003), 51–63.
61. 61 Quach, T.T., Duchemin, A.-M., Rogemond, V., Aguera, M., Honnorat, J., Belin, M.-F., et al. Involvement of collapsin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons. Mol Cell Neurosci 25 (2004), 433–443.
62. 62 Eliseeva, I.A., Kim, E.R., Guryanov, S.G., Ovchinnikov, L.P., Lyabin, D.N., Y-box-binding protein 1 (YB-1) and its functions. Biochemistry (Mosc) 76 (2011), 1402–1433.
63. 63 Hashimoto, T., Hussien, R., Cho, H.-S., Kaufer, D., Brooks, G.A., Evidence for the mitochondrial lactate oxidation complex in rat neurons: demonstration of an essential component of brain lactate shuttles. PLoS One, 3, 2008, e2915.
64. 64 Braunschweig, D., Krakowiak, P., Duncanson, P., Boyce, R., Hansen, R.L., Ashwood, P., et al. Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry, 3, 2013, e277.
65. 65 Diamond, B., Huerta, P.T., Losing your nerves? Maybe it's antibodies. Nat Rev Immunol 9 (2009), 449–456.
66. 66 Diamond, B., Honig, G., Mader, S., Brimberg, L., Volpe, B.T., Brain-reactive antibodies and disease. Annu Rev Immunol 31 (2013), 345–385.
67. 67 Martin, L.A., Ashwood, P., Braunschweig, D., Cabanlit, M., Van de Water, J., Amaral, D.G., Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 22 (2008), 806–816.
68. 68 Bauman, M.D., Iosif, A.-M.M., Ashwood, P., Braunschweig, D., Lee, A., Schumann, C.M., et al. Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl Psychiatry, 3, 2013, e278.
69. 69 Braunschweig, D., Golub, M.S., Koenig, C.M., Qi, L., Pessah, I.N., Van de Water, J., et al. Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model. J Neuroimmunol 252 (2012), 56–65.
70. 70 Singer, H.S., Morris, C., Gause, C., Pollard, M., Zimmerman, A.W., Pletnikov, M., Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model. J Neuroimmunol 211 (2009), 39–48.
71. 71 Camacho, J., Jones, K., Miller, E., Ariza, J., Noctor, S., Van de Water, J., et al. Embryonic intraventricular exposure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behaviors in offspring mice. Behav Brain Res 266 (2014), 46–51.
72. 72 Martínez-Cerdeño, V., Camacho, J., Fox, E., Miller, E., Ariza, J., Kienzle, D., et al. Prenatal exposure to autism-specific maternal autoantibodies alters proliferation of cortical neural precursor cells, enlarges brain, and increases neuronal size in adult animals. Cereb Cortex 26 (2016), 374–383.
73. 73 Benros, M.E., Eaton, W.W., Mortensen, P.B., The epidemiologic evidence linking autoimmune diseases and psychosis. Biol Psychiatry 75 (2014), 300–306.
74. 74 Heath, R.G., Krupp, I.M., Schizophrenia as an immunologic disorder: I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch General Psychiatry 16 (1967), 1–9.
75. 75 Patterson, P.H., Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav Brain Res 204 (2009), 313–321.
76. 76 Margari, F., Petruzzelli, M.G., Mianulli, R., Campa, M.G., Pastore, A., Tampoia, M., Circulating anti-brain autoantibodies in schizophrenia and mood disorders. Psychiatry Res 230 (2015), 704–708.
77. 77 Margari, F., Petruzzelli, M.G., Mianulli, R., Toto, M., Pastore, A., Bizzaro, N., et al. Anti-brain autoantibodies in the serum of schizophrenic patients: A case-control study. Psychiatry Res 210 (2013), 800–805.
78. 78 Kansy, J.W., Katsovich, L., McIver, K.S., Pick, J., Zabriskie, J.B., Lombroso, P.J., et al. Identification of pyruvate kinase as an antigen associated with Tourette syndrome. J Neuroimmunol 181 (2006), 165–176.
79. 79 Martino, D., Defazio, G., Church, A.J., Dale, R.C., Giovannoni, G., Robertson, M.M., et al. Antineuronal antibody status and phenotype analysis in Tourette's syndrome. Mov Disord 22 (2007), 1424–1429.
80. 80 Murphy, T.K., Kurlan, R., Leckman, J., The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: A way forward. J Child Adolesc Psychopharmacol 20 (2010), 317–331.
81. 81 Cheng, Y.-h, Zheng, Y., He, F., Yang, J.-h, Li, W.-b, Wang, M.-l, et al. Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome. J Mol Neurosci 48 (2012), 219–224.
82. 82 Elamin, I., Edwards, M.J., Martino, D., Immune dysfunction in Tourette syndrome. Behav Neurol 27 (2013), 23–32.
83. 83 Hornig, M., Lipkin, W.I., Immune-mediated animal models of Tourette syndrome. Neurosci Biobehav Rev 37 (2013), 1120–1138.
84. 84 Martino, D., Madhusudan, N, Zis, P, Cavanna, AE, An introduction to the clinical phenomenology of Tourette syndrome. Int Rev Neurobiol 112 (2013), 1–33.
85. 85 Bhattacharyya, S., Khanna, S., Chakrabarty, K., Mahadevan, A., Christopher, R., Shankar, S.K., Anti-brain autoantibodies and altered excitatory neurotransmitters in obsessive-compulsive disorder. Neuropsychopharmacology 34 (2009), 2489–2496.
86. 86 Gause, C., Morris, C., Vernekar, S., Pardo-Villamizar, C., Grados, M.A., Singer, H.S., Antineuronal antibodies in OCD: Comparisons in children with OCD-only, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol 214 (2009), 118–124.
87. 87 Guiseppe, M., Albert, U., Bogetto, F., Borghese, C., Berro, A.C., Mutani, R., et al. Anti-brain antibodies in adult patients with obsessive-compulsive disorder. J Affect Disord 116 (2009), 192–200.
88. 88 Silva, S.C., Correia, C., Fesel, C., Barreto, M., Coutinho, A.M., Marques, C., et al. Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunol 152 (2004), 176–182.
89. 89 Singer, H.S., Morris, C.M., Williams, P.N., Yoon, D.Y., Hong, J.J., Zimmerman, A.W., Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 178 (2006), 149–155.
90. 90 Wills, S., Cabanlit, M., Bennett, J., Ashwood, P., Amaral, D., Van de Water, J., Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci 1107 (2007), 79–91.
91. 91 Goines, P., Haapanen, L., Boyce, R., Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun 25 (2011), 514–523.
92. 92 Morris, C.M., Zimmerman, A.W., Singer, H.S., Childhood serum anti-fetal brain antibodies do not predict autism. Pediatr Neurol 41 (2009), 288–290.
93. 93 Cabanlit, M., Wills, S., Goines, P., Ashwood, P., Van de Water, J., Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci 1107 (2007), 92–103.
94. 94 Wills, S., Rossi, C.C., Bennett, J., Martinez Cerdeño, V., Ashwood, P., Amaral, D.G., et al. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol Autism 2 (2011), 1–5.
95. 95 Kowal, C., Athanassiou, A., Chen, H., Diamond, B., Maternal antibodies and developing blood-brain barrier. Immunol Res 63 (2015), 18–25.
96. 96 Coutinho, E., Harrison, P., Vincent, A., Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective. Biol Psychiatry 75 (2014), 269–275.
97. 97 Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 19 (2014), 1143–1149.